John Libbey Eurotext

Myoclonic encephalopathy caused by chronic bismuth abuse (Published with video sequence.) Volume 4, numéro 4, December 2002

1. Krüger G. Wismuth-Enzephalopathie. Fortschr Neurol Psychiat 1984; 52: 24-31.

2. Jungreis AC, Schaumburg H. Encephalopathy from abuse of bismuth subsalicylate (Pepto-Bismol). Neurology 1993; 43: 1265.

3. Molina JA, Jimenez-Jimenez FJ, Calandre L. Bismuth encephalopathy. Neurology 1994; 44 (3 Pt 1): 582.

4. Burns R, Thomas DW, Barron VJ. Reversible encephalopathy possibly associated with bismuth subgallate ingestion. Brit Med J 1974; 1: 220-3.

5. Buge A, Rancurel G, Dechy H. Encéphalopathies myocloniques bismuthiques formes évolutives, complications tardives durables ou définitives. Rev Neurol 1977; 133: 401-15.

6. Buge A, Supino-Viterbo V, Rancurel G, Pontes C. Epileptic phenomena in bismuth toxic encephalopathy. J Neurol Neurosurg Psychiatry 1981; 44: 62-7.

7. von Bose MJ, Zaudig M. Encephalopathy resembling Creutzfeldt-Jakob disease following oral, prescribed doses of bismuth nitrate. Br J Psychiatry 1991; 158: 278-80.

8. Supino-Viterbo V, Sicard C, Risvegliato M, Rancurel G, Buge A. Toxic encephalopathy due to ingestion of bismuth salts: clinical and EEG studies of 45 patients. J Neurol Neurosurg Psychiatry 1977; 40: 748-52.

9. Hallett M, Chadwick D, Marsden CD. Cortical reflexmyoclonus. Neurology 1979; 29: 1107-25.

10. Krüger G, Thomas DJ, Weinhardt F, Hoyer S. Disturbed oxidative metabolism in organic brain syndrome by bismuth in skin creams. Lancet 1976; 1: 485-7.

11. Krari N, Mauras Y, Allain P. Enhancement of bismuth toxicity by L-cysteine. Res Commun Mol Pathol Pharmacol 1995; 89: 357-64.

12. Olive G. Recherche menées par l’INSERM sur les encéphalopathies myocloniques provoquées par les sels insolubles de bismuth utilisés en gastro-entérologie. Thérapie 1980; 35: 305-6.

13. Obeso JA, Viteri C, Martinez Lage JM, Mardsen CD. Toxic myoclonus. Adv Neurol 1986; 43: 225-30.

14. Gordon MF, Abrahams R, Rubin DB, Barr WB, Correa D. Bismuth subsalicylate toxicity as a cause of prolonged encephalopathy with myoclonus. Mov Disord 1995; 10: 220-2.

15. Slikkerveer A, de Wolff F. Bismuth: biokinetics and neurotoxicity. Handbook Clin Neurol 1994; 20: 331-51.

16. Molina JA, Calandre L, Bermejo F. Myoclonic encephalopathy due to bismuth salts: treatment with dimercapton and analysis of CSF transmitters. Acta Neurol Scand 1989; 79: 200-3.

17. Playford RJ, Matthews CH, Campbell MJ, Delves HT, Hla KK, Hodgson HJ, Calam J. Bismuth-induced encephalopathy caused by tri-potassium dicitrato bismuthate in a patient with chronic renal failure. Gut 1990; 31: 359-60.

18. Slikkerveer A, Noach LA, Tytgat GNL, van der Voet G, de Wolff FA. Comparison of enhanced elimination of bismuth in humans after treatment with meso-2,3-dimercaptosuccinic and D,L-2,3-dimercaptopropane-1-sulfonic acid. Analyst 1998; 123: 91-2.